Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Advanced Solid Tumors × adavosertib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Ovarian Neoplasms 5 Small Cell Lung Carcinoma 4 Advanced Solid Tumours 4 Neoplasms 3 Leukemia, Myeloid, Acute 3 Glioblastoma 3 Fallopian Tube Neoplasms 3 Uterine Cervical Neoplasms 2 Triple Negative Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Neoplasm Metastasis 2 Lung Neoplasms 2 Advanced Malignant Solid Neoplasm 2 Vaginal Neoplasms 1 Uterine Neoplasms 1 Triple-negative Metastatic Breast Cancer 1 Stomach Neoplasms 1 Solid Tumors 1 Rhabdomyosarcoma 1 Prostatic Neoplasms 1 Platinum Refractory Extensive-Stage Small Cell Lung Carcinoma 1 Pinealoma 1 Pancreatic Neoplasms 1 Ovarian, Fallopian Tube, Peritoneal Cancer, P53 Mutation 1 Neuroectodermal Tumors, Primitive 1 Neuroblastoma 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Muscle Invasive Bladder Cancer 1 Multiple Myeloma 1

Interventions

Injections 21 Carboplatin 16 Docetaxel 13 Paclitaxel 10 Bevacizumab 10 pembrolizumab 9 Fluorouracil 7 Cisplatin 7 durvalumab 6 Nivolumab 6 Leucovorin 6 trifluridine tipiracil drug combination 5 tislelizumab 5 linifanib 5 Pemetrexed 5 talazoparib 4 olaparib 4 Panobinostat 4 Oxaliplatin 4 Itraconazole 4 Irinotecan 4 Capecitabine 4 zimberelimab 3 toripalimab 3 sintilimab 3 fludarabine 3 depatuxizumab 3 atezolizumab 3 Sorafenib 3 ST 1481 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05008913 2022-09-06

ADME

AstraZeneca

Phase 1 Terminated

Other solid neoplasm

Advanced Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡